Effervescent Products Market Size, Share, and Growth Forecast for 2025 - 2032

Effervescent Products Market by Form (Tablets, Powder, Granules), Indication (Digestive Disorders, Vitamin and Mineral Deficiency, Pain and Inflammation), Application, Distribution Channel, and Regional Analysis from 2025 to 2032

Industry: Healthcare

Published Date: January-2025

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 198

Report ID: PMRREP17614

Report Price

$ 4995*

Buy Now

Effervescent Products Market Size and Share Analysis

The global effervescent products market is estimated to reach a size of US$ 60.2 Bn in 2025. It is predicted to rise at a CAGR of 7% through the assessment period to attain a value of US$ 133.8 Bn by 2032.

Demand for effervescent products is rising owing to consumers' growing need for accessible and creative health and wellness solutions. Effervescent tablets are gaining traction due to their quick-dissolving properties, high bioavailability, and ability to mask unpleasant tastes, making them particularly appealing to children and the elderly. For example,

  • In January 2023, Bayer AG extended its range of Berocca effervescent tablets to include more vitamin-rich formulations targeting immunity and energy support.

Demand for dietary supplements and preventive healthcare propels the market. Players like GlaxoSmithKline (with its Redoxon brand) are focusing on sustainable and travel-friendly packaging to cater to environmentally conscious consumers. Effervescent solutions are becoming increasingly well-liked because of how well and conveniently they give vitamins, minerals, and electrolytes.

Key Highlights of the Markets

  • Consumers are increasingly seeking convenient and enjoyable delivery methods for supplements and medications.
  • The awareness of health and wellness is boosting the demand for convenient and easily digestible nutritional products.
  • The innovation in taste profiles and functional additives is impacting the digestible supplement industry.
  • The demand for vitamins, minerals, and dietary supplements is fostering product growth in digestible products.
  • In 2025, effervescent tablets are estimated to attain a market share of 40% due to its quick effectiveness.
  • Based on indication, digestive disorders are projected to account for a market share of 35% in 2025 due to its prevalence across the world.
  • North America's market share is predicted to reach 38% in 2025 due to advancements in healthcare infrastructure.
  • Europe is anticipated to hold a market share of 30% in 2025 with the robust EU’s healthcare regulations.

Market Attributes

Key Insights

Effervescent Products Market Size (2025E)

US$ 60.2 Bn

Projected Market Value (2032F)

US$ 133.8 Bn

Global Market Growth Rate (CAGR 2025 to 2032)

7%

Historical Market Growth Rate (CAGR 2019 to 2023)

6.1%

North America’s Robust Healthcare Infrastructure Offers Potential

North America is projected to hold 38% of the global market share in 2025, driven by consumer awareness of health and wellness. The region’s market is set to draw a CAGR of 6% from 2025 to 2032.

Companies like Amway, Abbott, and Herbalife Nutrition lead the market, offering innovative products targeting specific health needs. For instance,

  • In June 2023, Abbott introduced a plant-based Ensure nutrition shake with added protein and fiber to support digestive health.

The U.S. Food and Drug Administration's (FDA) emphasis on promoting functional ingredients in foods has encouraged industry players to expand product portfolios. Growing focus on preventive healthcare and personalized nutrition strengthens North America's market position.

Favorable Regulatory Infrastructure of Europe to Boost Pharma Investments

Europe is poised to hold a 30% share of the global effervescent products market in 2025, with the region set to report a CAGR of 5.5% from 2025 to 2032. High demand, especially in nations like Germany, France, and the U.K., for novel and practical health supplements is the reason for the development of Europe. Demand for immunity-boosting effervescent formulations has surged, especially post-pandemic, as consumers prioritize preventive healthcare.

Companies like Hermes Pharma and Bayer AG lead Europe, offering a wide range of effervescent tablets targeting various health concerns, including digestion and immune support. For example,

  • In April 2023, Hermes Pharma launched a new line of sugar-free effervescent products to cater to health-conscious consumers.

The EU's regulatory focus on product safety and efficacy has further fostered consumer trust in regional products, thereby promoting their adoption in the nutraceutical and pharmaceutical sectors. 

Consumers Opt for Effervescent Tablets for Gaining Better Results

In 2025, effervescent tablets are projected to hold 40% of the market share, driven by their easy availability, cost-effectiveness, and convenience. Effervescent pills are well-liked by health-conscious customers because they dissolve rapidly in water and effectively deliver vitamins, minerals, and prescription drugs. In 2023, sales of effervescent tablets rose by 9% worldwide.

  • In October 2023, Bayer launched its next-generation Redoxon effervescent tablets, featuring enhanced vitamin C formulations for immune support.
  • In November 2023, GlaxoSmithKline launched Eno effervescent antacid pills to provide digestive health treatments in developing nations.

Tablets remain the top choice in the effervescent products market due to their portable, easy-to-use nature and advancements in effervescent formulations.

Rising Prevalence of Digestive Disorders to Boost Demand for Effervescent Solutions

Digestive disorders are set to dominate the global market, accounting for 35% of the total share in 2025. The prevalence of gastrointestinal issues like irritable bowel syndrome (IBS), acid reflux, and bloating is a key driver, with an estimated 40% of the global population experiencing functional gastrointestinal disorders as of 2023.

Rising health consciousness has led consumers to prioritize gut health, fueling demand for probiotics, prebiotics, and fiber-enriched products. Key players like Yakult Honsha and Danone are capitalizing on this trend. For instance,

  • Sales of Danone's Activia line of probiotic yogurts increased significantly in 2023 owing to the company's global "Gut Health" promotion.
  • In March 2023, Nestlé Health Science introduced a line of supplements aimed at digestive health under the Garden of Life brand.

The focus on digestive health is supported by increasing clinical research linking gut microbiota to drive market expansion.

Market Introduction and Trend Analysis

The market for effervescent products is booming as more consumers prefer convenient and enjoyable ways to take supplements and medications. People are becoming more aware of health and wellness, increasing the demand for easy-to-consume nutritional products.

New flavors and functional ingredients are creating more opportunities in this market. Quick-dissolving, portable health supplements are gaining popularity. As the vitamins, minerals, and dietary supplements markets expand, product growth continues.

There is also a rising interest in hydration and electrolyte products, with effervescent formulas being adopted more in both the pharmaceutical and nutraceutical areas. Trends in health supplements include key nutraceutical companies launching new effervescent lines, pharmaceutical companies creating unique effervescent medications, and growth of functional beverages. However, production costs and packaging challenges can limit growth, especially in the sports nutrition and children's health markets.

The global market is rising, with an 80% increase in interest for convenient health supplements in emerging markets. Important focus areas include personalized nutrition solutions, natural and organic ingredients, advanced flavors, and innovative packaging designs.

Historical Growth and Course Ahead

The global effervescent solutions market recorded a CAGR of 6.1% in the historical period from 2019 to 2023. Effervescent goods' ease of swallowing, rising health consciousness, technical developments, and creative dosage forms in healthcare are projected to contribute to the market growth for digestible products.

Strong immunity is crucial, and the worldwide outbreak has affected this industry by raising demand for vitamins, minerals, and nutritional supplements. For example,

  • In October 2019, Bayer AG launched LifeHub UK, focusing on Artificial Intelligence for data-driven drug discovery and disease diagnosis. GlaxoSmithKline Plc introduced Intravenous Benylsta, which was approved by the European Commission for children with lupus.
  • In September 2019, Reckbitt Benckiser Group PLC acquired TerraCycle, a recycling leader, to offer consumers a simple and free way to recycle consumer goods packaging.
  • Herbalife International of America, Inc. opened 29 Casa Herbalife Nutrition programs and donated US$ 4 Mn to support nutrition programs.
  • In July 2019, DMK Group established a high-tech baby food plant in Strückhausen, investing US$ 158.05 Mn.

Demand for effervescent tablets is estimated to record a considerable CAGR of 7% during the forecast period between 2025 and 2032.

Market Growth Drivers

Rising Health Consciousness among Consumers

The awareness of health and wellness, coupled with rising disposable incomes, has fueled the demand for dietary supplements, probiotics, vitamins, and minerals globally. Companies like Nestlé Health Science and Amway have expanded their portfolios to meet evolving consumer preferences. For example,

  • In March 2023, Nestlé launched new plant-based functional nutrition products under the Garden of Life brand, targeting the demand for sustainable and health-focused solutions.

The probiotic segment is gaining momentum due to its benefits in gut health, with companies such as Danone and Yakult driving innovation. The dietary supplements in 2025 emphasize the shift toward preventive healthcare and personalized nutrition.

Rapid Innovations in Effervescent Technology

Effervescent technology is redefining the healthcare sector in response to customer needs for improved user experience, convenient solutions, and health-conscious options. Low-calorie, sugar-free effervescent pills are well-liked by consumers who are concerned about their health as well as those who are treating diseases like diabetes or obesity.

Advanced effervescent drug formulations have been produced by pharmaceutical companies, increasing flavor characteristics and patient compliance. For better patient experience, key hospital networks suggest these products. Increased research and development efforts are propelling the demand for effervescent products as businesses create innovative drugs that improve patients' health and way of life.

In addition to saving plastic, effervescent items that may be turned into drinks also help the environment by making medications simpler to consume. In the next ten years, it is anticipated that significant expenditures in cutting-edge technology and fizzy goods will generate promising opportunities for market growth.

Market Restraining Factors

High Production Cost may Hamper the Healthcare Sector

Lack of healthcare infrastructure, availability in developing nations, and the high costs of medicine research are some of the issues facing the demand for effervescent products. Effervescent products' high sodium content, which helps dissolve and fizz fluids, has been connected to health problems like high blood pressure and cardiovascular diseases.

Comparing effervescent formulations to conventional tablet or capsule formats, production costs have gone up by 30 to 40%, which can restrict market growth. Advanced moisture-resistant solutions are required because of the considerable packaging problem of moisture sensitivity.

Traditional tablets or capsules may limit the convenience of effervescent tablets. Hence, consumers should be informed about the resources offered and the advantages of these products. Expanding the market requires educating consumers and medical professionals about the effectiveness and appropriate usage of such pills.

Key Market Opportunities

Development of Quick-dissolving and Portable Health Supplements

Demand for quick-dissolving, portable health supplements is surging as consumers prioritize convenience and efficacy in their wellness routines. Effervescent formulations, which dissolve rapidly in water, are gaining popularity in the pharmaceutical and nutraceutical sectors due to their improved bioavailability and ease of consumption.

Companies like Bayer AG and Haleon have capitalized on this trend, with products like Berocca and Redoxon gaining significant market traction. For instance,

  • In July 2023, Haleon extended its effervescent product line in the Asia-Pacific to meet the rising demand for immunity-boosting supplements.
  • Nuun Hydration, a U.S.-based company, reported a 25% increase in effervescent tablet sales in 2022, driven by fitness enthusiasts seeking hydration solutions.

The portable and mess-free nature of these products aligns with the lifestyle of on-the-go consumers, fueling adoption in developed and emerging nations.

Modernization in Flavor Profiles and Launch of Functional Ingredients

Innovation in flavor profiles and functional ingredients is propelling the dietary supplements and functional foods industry, unlocking novel growth opportunities. Consumers increasingly seek products that combine health benefits with enjoyable taste experiences.

Consumer health consciousness, convenience, and taste appeal are driving the 45% market share for applications in nutritional supplements, driven by increased bioavailability and taste appeal. Companies are responding by introducing innovative flavors and nutrient combinations. For instance,

  • In April 2023, PepsiCo expanded its Gatorade portfolio with new electrolyte drinks featuring fruit-infused flavors and added functional benefits like immunity support.
  • In February 2023, Nestlé launched its BOOST line, which combines fiber and protein with tastes tailored to local markets.

The trend toward personalization is fueling innovation, with brands like Herbalife Nutrition introducing customizable powders and gummies. The focus on taste and functionality drives consumer engagement and widens market appeal.

Competitive Landscape for the Effervescent Products Market

In order to extend their product range, income, and lifetime, prominent competitors in the fiercely competitive effervescent products market are concentrating on creating easily navigable dosage forms such as effervescent tablets, powders, and granules. To keep ahead of the competition, manufacturers need to make investments in digital technology, eco-friendly procedures, and the newest scientific findings.

Quick product delivery can result from investments in digital technology that increase productivity, lower costs, and simplify manufacturing. Industry growth and product line diversification can open up new markets and generate more income. Diversification may provide customers with more options to suit their individual requirements and interests, while incorporating the most recent scientific findings can lead to goods with enhanced functionality and efficacy.

Recent Industry Developments

  • In November 2024, Hometown Hero, a Texas-based cannabis brand, introduced a new line of effervescent canned lemonades containing 25mg Delta-9 THC, blended with natural flavors and ingredients.
  • In November 2024, Berocca, the expert nutritional supplement brand by Bayer Consumer Health, launched a new product innovation exclusively on Amazon called Berocca Mind.
  • In November 2024, Berocca launched several products in Australia, including Berocca Hydrate and Berocca Go, aimed at addressing new consumer needs in mental and emotional health.
  • In September 2024, Chulalongkorn University developed Thai herbal effervescent tablets with fruit flavor, combining Thai herbs and fruits with Deep Tech technology for modern consumers.
  • In September 2024, Airborne, a Reckitt brand, launched its most complete immune support mix, which includes effervescent and chewable pills enhanced with more zinc, vitamin D, and vitamin C.
  • In August 2024, Perrigo UK launched SolpaOne, its first maximum strength paracetamol tablet, offering fast pain relief for headaches, back pain, and everyday pain, suitable for low sodium diets.
  • In August 2024, INJA Wellness introduced India's first Liposomal Glutathione Effervescent Tablets, promoting radiant skin, immunity, acne reduction, and oxidative stress through advanced Liposomal Technology.
  • In June 2024, Plix, a leading plant-based nutrition brand in India, appointed Shehnaaz Gill as its new brand ambassador for Apple Cider Vinegar Effervescent, promoting healthy lifestyles and releasing two new films for their #WeightLossKaBigBoss campaign.

Effervescent Products Market Report Scope

Attributes

Details

Forecast Period

2025 to 2032

Historical Data Available for

2019 to 2023

Market Analysis

US$ Billion for Value

Key Regions Covered

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Key Market Segments Covered

  • Form
  • Indication
  • Application
  • Distribution Channel
  • Region

Key Companies Profiled in the Report

  • Reckitt Benckiser Group Plc
  • Bayer AG
  • Nuun and Company Inc.
  • Bristol-Myers Squibb Co (UPSA Laboratories)
  • Herbalife International of America, Inc.
  • Prestige Brands, Inc.
  • DMK Group (Sanotact GmbH)
  • Hermes Arzneimittel GmbH
  • Pyramid Pharmaceuticals
  • Amerilab Technologies Inc.
  • US Pharma Lab Incorporated
  • Tower Laboratories, Ltd
  • Laboratoires SMB
  • Paragon Labs USA
  • Marlyn Nutraceuticals, Inc.
  • JW Nutritional, LLC
  • Nomax Inc.
  • Nutrilo GmbH
  • Bhumija lifesciences
  • Others

Report Coverage

  • Market Forecast and Trends
  • Company Share Analysis
  • Competitive Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives  

Customization and Pricing

Available upon request

Effervescent Products Market Segmentation

By Form      

  • Tablets
  • Powder
  • Granules

By Indication  

  • Digestive Disorders
  • Vitamin and Mineral Deficiency
  • Pain and Inflammation
  • Respiratory Disorders
  • Diuretic
  • Oral Health
  • Others

By Application 

  • Nutritional Supplements
  • Pharmaceuticals
  • Dental Application
  • Others

By Distribution Channel     

  • Pharmacies and Drugstores
  • Supermarkets and Hypermarkets
  • Online Retail

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Reckitt Benckiser Group Plc
  • Bayer AG
  • Nuun and Company Inc.
  • Bristol-Myers Squibb Co (UPSA Laboratories)
  • Herbalife International of America, Inc.
  • Prestige Brands, Inc.
  • DMK Group (Sanotact GmbH)
  • Hermes Arzneimittel GmbH
  • Pyramid Pharmaceuticals
  • Amerilab Technologies Inc.
  • US Pharma Lab Incorporated
  • Tower Laboratories, Ltd
  • Laboratoires SMB
  • Paragon Labs USA
  • Marlyn Nutraceuticals, Inc.
  • JW Nutritional, LLC
  • Nomax Inc.
  • Nutrilo GmbH
  • Bhumija lifesciences
  • Others

Frequently Asked Questions

The market size is set to reach US$ 133.8 Bn by 2032.

Effervescent tablets are formed by compressing granules containing citric acid and sodium bicarbonate, which react with water to generate carbon dioxide gas bubbles.

In 2025, North America is set to attain a market share of 38%.

In 2025, the market is estimated to be valued at US$ 60.2 Bn.

Reckitt Benckiser Group Plc, Bayer AG, Nuun and Company Inc., Bristol-Myers Squibb Co (UPSA Laboratories), and Herbalife International of America, Inc. are a few key players.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate